BioSpace News Archive

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported preliminary* fourth quarter and full-year 2023 net product revenue and cash on hand as of December 31, 2023, as part of its presentation today at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, Calif.

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its Percept™ RC Deep Brain Stimulation (DBS) system.

Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced a research collaboration with NVIDIA to accelerate the development and adoption of advanced computer vision solutions in life sciences.

Paterna Biosciences is pleased to announce Dr. Kyle Orwig has joined the company as a co-founder.

FluoGuide A/S is pleased to provide an update on its corporate strategy and plans for further clinical development and commercialization of its lead product FG001.

RadNet, Inc. announced that Dr. Howard Berger, President and Chief Executive Officer and Mark Stolper, Executive Vice President and Chief Financial Officer will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 10, 2024 at 4:30 p.m. PST.

Zura Bio Limited announced the appointments of Robert Lisicki as President and Chief Operating Officer, and Kiran Nistala, MBBS, PhD, as Executive Vice President Development and Chief Medical Officer, to the Executive Leadership Team.

Caris Life Sciences® and Flatiron Health announced a partnership to create a multimodal data offering to support and accelerate biopharmaceutical drug development and patient care.

Nuvalent, Inc. announced its “OnTarget 2026" operating plan to guide efforts towards having its first potential approved product in 2026.

Sage Therapeutics, Inc. announced that Chief Executive Officer Barry Greene will discuss the Company’s key business drivers for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California.